Clinical Trial Update: A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 pilot trial in Kenya evaluated the safety, acceptability, and adherence of Pre-Exposure Prophylaxis (PrEP) in at-risk populations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: International AIDS Vaccine Initiative | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED